DeepMed Research

UNICANCER

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Established: 1964-01-01

Employees: 101

Market Cap: -

Website: http://www.unicancer.fr

Clinical Trials

Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment

Phase 3

Active, not recruiting

Conditions: Ovarian Epithelial Cancer Recurrent

Interventions: Procedure: Maximal cytoreductive surgery
Drug: HIPEC

First Posted Date: 2011-06-20

Last Posted Date: 2025-04-23

Lead Sponsor: UNICANCER

Target Recruit Count: 415

Registration Number: NCT01376752

Locations: 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇫🇷
Polyclinique Kéraudren, Brest, France
🇫🇷
Institut Bergonie, Bordeaux, France

and more 30 locations

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Phase 3

Terminated

Conditions: Stage IB2 Cervical Cancer
Stage II Cervical Cancer
Adenocarcinoma
Squamous Cell Carcinoma
Adenosquamous Carcinoma

Interventions: Procedure: hysterectomy

First Posted Date: 2011-06-01

Last Posted Date: 2011-06-01

Lead Sponsor: UNICANCER

Target Recruit Count: 61

Registration Number: NCT01363466

Locations: 🇫🇷
Clinique Sainte Thérèse de l'enfant Jésus, Amiens, France
🇫🇷
Clinique Axium, Aix-en-Provence, France
🇫🇷
Centre Hospitalier Universitaire, Amiens, France

and more 32 locations

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Phase 3

Completed

Conditions: Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer

Interventions: Drug: gemcitabine hydrochloride
Other: clinical observation
Drug: oxaliplatin
Procedure: adjuvant therapy
Procedure: quality-of-life assessment

First Posted Date: 2011-03-11

Last Posted Date: 2017-01-25

Lead Sponsor: UNICANCER

Target Recruit Count: 190

Registration Number: NCT01313377

Locations: 🇫🇷
Hôpital Jean Minjoz, Besancon, France
🇫🇷
Hôpital Saint Joseph, Marseille, France
🇫🇷
Hôpital Nord, Marseille, France

and more 34 locations

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Phase 2

Completed

Conditions: 70 Years Old Patients and Over
Metastatic Breast Cancer
After One Line of Chemotherapy With Trastuzumab

Interventions: Drug: lapatinib + capecitabine

First Posted Date: 2010-12-17

Last Posted Date: 2014-12-16

Lead Sponsor: UNICANCER

Target Recruit Count: 4

Registration Number: NCT01262469

Locations: 🇫🇷
Centre Hospitalier de Lagny-Sur-Marne, Lagny-sur-Marne, France
🇫🇷
Institut Claudius Regaud, Toulouse, France
🇫🇷
Polyclinique de Courlancy, Reims, France

and more 17 locations

Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel every 3 weeks + Prednisone
Drug: Docetaxel weekly+ Prednisone

First Posted Date: 2010-12-06

Last Posted Date: 2021-06-10

Lead Sponsor: UNICANCER

Target Recruit Count: 66

Registration Number: NCT01254513

Locations: 🇫🇷
Centre Paul Papin, Angers, France
🇫🇷
Clinique Claude Bernard, Albi, France
🇫🇷
CHI Annemasse-Bonneville, Ambilly, France

and more 28 locations

Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Lumpectomy
Breast Cancer

Interventions: Radiation: Accelerated partial breast irradiation
Radiation: Whole Breast Irradiation + Boost or Hypofractionated irradiation

First Posted Date: 2010-11-24

Last Posted Date: 2025-05-14

Lead Sponsor: UNICANCER

Target Recruit Count: 1006

Registration Number: NCT01247233

Locations: 🇫🇷
Centre de traitement des Hautes energie - Clinique de l'Europe, Amiens, France
🇫🇷
Centre Hospitalier Universitaire, Amiens, France
🇫🇷
Centre Paul Stauss, Strasbourg, France

and more 30 locations

Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Metastatic Cancer
Solid Tumors

Interventions: Drug: cisplatin
Drug: Pazopanib

First Posted Date: 2010-07-19

Last Posted Date: 2014-11-17

Lead Sponsor: UNICANCER

Target Recruit Count: 35

Registration Number: NCT01165385

Locations: 🇫🇷
Centre Georges François LECLERC, Dijon, France
🇫🇷
Institut Curie, Paris, France
🇫🇷
Centre Léon Berard, Lyon, France

and more 2 locations

Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: 3-dimensional conformal radiation therapy
Radiation: intensity-modulated radiation therapy

First Posted Date: 2009-08-28

Last Posted Date: 2024-12-18

Lead Sponsor: UNICANCER

Target Recruit Count: 500

Registration Number: NCT00967863

Locations: 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷
Centre hospitalier Métropole Savoie, Chambéry, France
🇫🇷
Clinique PASTEUR, Toulouse, France

and more 22 locations

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

Phase 2

Completed

Conditions: Breast Cancer
Metastatic Cancer

Interventions: Drug: capecitabine
Drug: lapatinib ditosylate
Other: circulating tumor cell analysis
Other: laboratory biomarker analysis

First Posted Date: 2009-08-27

Last Posted Date: 2013-01-18

Lead Sponsor: UNICANCER

Target Recruit Count: 45

Registration Number: NCT00967031

Locations: 🇫🇷
Centre Leon Berard, Lyon, France

Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer

Phase 2

Terminated

Conditions: Anal Cancer

First Posted Date: 2009-08-10

Last Posted Date: 2020-02-11

Lead Sponsor: UNICANCER

Target Recruit Count: 16

Registration Number: NCT00955240

Locations: 🇫🇷
Centre Regional Rene Gauducheau, Nantes-Saint Herblain, France
🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷
Centre Antoine Lacassagne, Nice, France

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy